Manuka Honey Guide: UMF/MGO Ratings & Best Brands 2026

What it is

The honey with the most rigorously verified chemistry — and the strictest authenticity standards in honey.

Manuka honey comes from bees foraging the Manuka tree — Leptospermum scoparium — a small, tough shrub native to New Zealand and the temperate regions of south-eastern Australia. The tree flowers for only 2–6 weeks a year, in late spring and early summer, and produces a honey with a distinctive chemical signature: dense, slow to pour, and carrying a compound called methylglyoxal (MGO) at concentrations far higher than other honeys.

Manuka is the most rigorously characterized honey in food science. It carries grading and authenticity certifications (UMF, MGO) backed by chemistry; a sterilized, FDA-cleared Class II wound dressing exists in a separate medical-device register (Medihoney — not the same as jarred consumer manuka; see the dedicated FAQ); and the honey itself has a deeper compositional research base than any other variety. This is honey with a printable, verifiable chemistry rating — and a marker-tested standard that exists because the fraud problem is real (more on that in the benefit cards).

The Māori people of New Zealand have used Manuka in te rongoā Māori (traditional healing practice) for centuries before European contact. European settlement brought commercial beekeeping; Peter Molan's lab at the University of Waikato characterized the antibacterial chemistry in the 1980s; the 2000s brought the Medihoney device clearance; the 2010s brought the MGO certification boom. Today you can buy Manuka with a printable, verifiable chemistry rating backed by independent testing. Few foods come with this degree of compositional transparency.

Quick facts

Color: Dark Amber· 132 mm Pfund
Sourced ✓
Source tree: Leptospermum scoparium
Top regions: East Cape, Northland, Coromandel
Bloom: Late spring to early summer (2–6 weeks)
Flavor: Earthy, herbal, medicinal, warming
Crystallization: Fast to moderate (weeks to 2–3 months)
Known for: High methylglyoxal content; strict authentication

The science

Methylglyoxal — the compound that makes Manuka special.

Every honey contains trace amounts of a compound called methylglyoxal (MGO) — a byproduct of glucose metabolism in the honey-making process. In most honeys, MGO sits at 1–10 mg/kg. In Manuka, it reaches 38–761 mg/kg. That difference is not incremental. It is the entire story.

MGO is a reactive alpha-dicarbonyl compound. In the human body at high concentrations, it is harmful — a marker of oxidative stress, implicated in diabetes complications and aging. But at the moderate concentrations present in Manuka honey, MGO is stable, antimicrobial, and highly measurable. This is the breakthrough: unlike the phenolic compounds and hydrogen peroxide that give other honeys antimicrobial properties (which degrade over time), MGO is shelf-stable. A jar of UMF 15+ Manuka from 2020 still carries its original MGO activity in 2026. This is why Manuka could be certified, and why the certification stuck.

The first detailed chemical characterization of Manuka's antibacterial chemistry came from Adams et al. (2008, Carbohydr Res), who used HPLC to isolate the bioactive fraction and identified methylglyoxal as a major bactericidal compound — while also showing that after MGO neutralization, Manuka retained partial bactericidal activity, indicating other antimicrobial components beyond MGO.

The source of Manuka's exceptional MGO content was not nailed down until Adams et al. (2009, Carbohydr Res) mapped the dihydroxyacetone-to-MGO conversion pathway — meaning most Manuka literature published before that was working backwards from the antibacterial effect without a confirmed mechanism. They tracked DHA in fresh Manuka honey (high), aged honey (low, with proportionally elevated MGO), and Manuka flower nectar (high DHA, no MGO), then confirmed the storage-driven conversion by spiking clover honey with DHA. Whatever the upstream triggers, the result is consistent: a Manuka honey tested in a New Zealand lab in 2024 will show MGO levels that correlate almost exactly with Manuka honey tested in 1998. Few food products offer that stability.

This is why Manuka commands a premium. Not because of mystique. Not because it is rare or hard to harvest. But because it is — quite literally — more of a specific, measurable, shelf-stable compound than any other honey on the market. A jar labeled UMF 15+ is not a subjective claim. It is a quantified assertion: this honey contains a minimum of 514 mg/kg MGO, and it will continue to contain roughly that amount for decades.

The MGO floor. Manuka requires 100 mg/kg MGO minimum to justify the name. Entry-tier Manuka (UMF 10+) sits at 263 mg/kg. Premium Manuka (UMF 15+) reaches 514 mg/kg. Top-tier (UMF 20+) exceeds 850 mg/kg. These are not suggestions — they are government-backed, laboratory-audited minimums. A jar that claims UMF 15+ and tests below 514 mg/kg is not a lesser Manuka. It is mislabeled, period.

Making sense of the labels

UMF, MGO, and NPA — three ways to measure the same thing.

Manuka is the only honey with three separate, overlapping certification systems. This redundancy exists because the science evolved over decades, and the market did not consolidate. But all three measure the same phenomenon: the honey's non-peroxide antimicrobial activity.

UMF (Unique Manuka Factor)

The original standard, established in the 1980s by New Zealand beekeeping research.

Measures: Three compounds: leptosperin, methylglyoxal (MGO), and non-peroxide antimicrobial activity (NPA)
Entry threshold: UMF 10+ ≈ entry grade
Premium threshold: UMF 15+ ≈ premium grade
Top tier: UMF 20+ ≈ maximum MGO
Best for: Buyers who want a three-point verification and don't want to interpret individual compound numbers

MGO (Methylglyoxal)

Direct measurement of the primary active compound.

Measures: Methylglyoxal content only (mg/kg)
Entry threshold: 100+ mg/kg (baseline Manuka)
Mid-grade threshold: 263+ mg/kg ≈ UMF 10+
Premium threshold: 514+ mg/kg ≈ UMF 15+
Best for: Buyers who want a single, transparent number and understand that MGO is the active ingredient

NPA (Non-Peroxide Activity)

The original bioassay method, largely superseded but still used.

Measures: Antimicrobial activity in a bacterial culture plate, minus hydrogen peroxide contribution
Entry threshold: NPA 5+
Correlation: NPA roughly correlates to MGO ÷ 100 (NPA 10+ ≈ MGO 1,000+)
Drawback: Assay is slower, less precise, and more subject to lab variation
Best for: Historical comparisons; rarely used on modern labels

The honest take: All three systems correlate. A jar labeled UMF 15+ will have roughly 514 mg/kg MGO and an NPA equivalent of 10+. The certification you choose matters less than the fact that the jar carries one, is verifiable (look for a batch number and registration), and comes from a reputable seller. Budget Manuka with no certification is a red flag. Manuka with any one of these three certifications, properly backed, is genuine.

The authenticity marker

Leptosperin — the fingerprint of real Manuka.

In 2014, Japanese researchers identified a compound unique to Manuka honey: leptosperin. It is produced only by Leptospermum scoparium nectar and is absent in every other honey tested. This discovery had one immediate implication: you could now test for Manuka's authenticity at the molecular level.

Leptosperin is present at roughly 3–10 mg/kg in real Manuka honey. It is not an active compound in the medicinal sense — it does not kill bacteria or provide antioxidants. It is simply a marker. But it is an infallible one. A honey claiming to be Manuka but testing negative for leptosperin is either not Manuka, or it is cut with other honey to below detectability. Either way, it is not genuine.

The discovery of leptosperin coincided with, and accelerated, the establishment of the MGO certification standard. By the mid-2010s, the New Zealand Ministry for Primary Industries (MPI) made leptosperin presence a requirement for any honey exported as "Manuka." This is not a best practice. It is law. Every jar of Manuka legally exported from New Zealand after 2015 contains detectable leptosperin.

This is why Manuka's authenticity problem is, paradoxically, more solvable than Sidr's or rare-origin honeys'. A single lab test — leptosperin presence, plus MGO measurement — proves whether a jar is genuine. You cannot fake leptosperin. You cannot synthesize it into commodity honey. It either exists in your jar or it does not. This is the scientific infrastructure that Manuka's certification system is built on.

For the buyer, this means: if you are spending on Manuka, and the seller cannot point you to a leptosperin test (or the label does not mention UMF or MGO certification), you are dealing with either fraud or negligence. Neither is acceptable for a certified specialty honey.

Who can call it ‘manuka’

Australia has its own Leptospermum — and New Zealand lost the trademark fight in three jurisdictions.

Manuka is a M&amacr;ori word for a plant that grows on both sides of the Tasman Sea. New Zealand spent more than a decade trying to reserve the name exclusively. Courts in three jurisdictions ruled the word belongs to no country — but the product distinction (different countries, different species, different certification frameworks) is still real.

Australia has roughly 80 native Leptospermum species, most notably L. polygalifolium and L. continentale, with smaller volumes from L. laevigatum and L. petersonii, growing across Tasmania, Victoria, New South Wales, and into southern Queensland. Cokcetin et al. (2016, PLOS ONE) measured MGO ranges in Australian Leptospermum samples that overlap directly with NZ Manuka UMF 10–15 territory: 80 samples tested, with the strongest L. polygalifolium examples reaching MGO up to 1100 mg/kg — the same range as medium-grade Manuka. The chemistry is real; the research base is less extensive than NZ L. scoparium, but the honey is legitimate in its own right.

New Zealand spent more than a decade trying to reserve the word “manuka” exclusively for L. scoparium honey produced in New Zealand. The bid lost in all three venues. In 2021, the UK Intellectual Property Office rejected New Zealand's certification-mark application. The European Union geographical-indication bid was rejected, not secured. And in May 2023, the Intellectual Property Office of New Zealand (IPONZ) itself ruled that “manuka” is a descriptive word that anyone can use — striking down the certification-mark application within New Zealand. The trio of rulings settled the question: manuka is a M&amacr;ori word for a plant that grows on both sides of the Tasman Sea, not a piece of intellectual property any country can own.

The M&amacr;ori-taonga argument carries weight in the cultural debate that produced these rulings. Iwi groups argued that “manuka” is part of the te reo M&amacr;ori language and a cultural taonga (treasure), not an industrial trademark — a position that aligned with the legal conclusion that the word is descriptive rather than proprietary.

The certification frameworks survive the naming ruling. New Zealand operates under UMF licensing plus the 2017 MPI legal definition (leptosperin + MGO + DHA + HMF minimums + DNA pollen). Australian producers operate under a Total Activity (TA) rating system measured by phenol-equivalent assay, plus direct MGO measurement on labels. Both are legitimate, trademarked grading marks owned by their respective associations — what changed is that the word “manuka” itself is legally available to either country's producers, while the grading marks remain owned by who owns them.

The practical buyer guidance is straightforward: read the country-of-origin line and the certification mark on the label. NZ + UMF gets you New Zealand L. scoparium; AU + TA gets you Australian Leptospermum. The word “manuka” alone no longer narrows it down.

Geography & tiers

Three New Zealand regions, three price points.

Most of New Zealand's Manuka comes from three regions. Bloom timing, beekeeper density, and competition structure differ across each, and so do the prices.

New Zealand — East Cape & Northland

Leptospermum scoparium — premium terroir

Highest MGO, Highest Price

The top-tier producing regions produce Manuka with MGO consistently above 800 mg/kg and UMF ratings of 20+. Helicopter-accessed apiaries, helicopter-harvested hives, and a handful of family operations dominating the export market for premium jars. This is allocation-only honey from serious importers.

What you get: single-origin, batch-numbered, leptosperin-verified jars with MGO or UMF ratings that consistently exceed their label minimums. The honey that lands on hospital dressing carts and in the toolkits of beekeeper-celebrities.

AvailabilityAllocation only

UMF20+ to 26+

New Zealand — Central & South North Island

Leptospermum scoparium — mid-range terroir

Mid-Tier Workhorse

The bulk of New Zealand's Manuka production comes from the central and southern North Island. These regions produce reliable UMF 10–15 honey year after year, with good MGO content (263–514 mg/kg) and less variation. This is where the commercial supply chain stabilizes: enough volume to justify import relationships, but tight enough QA that every batch is verifiable.

What you get: consistent certified Manuka backed by major producer cooperatives. The honey most retail buyers encounter. Single-origin, traceable, with government-backed certification. Not the pinnacle, but the real thing.

AvailabilitySpecialty retail

UMF10+ to 15+

New Zealand — South Island

Leptospermum scoparium — cooler climate terroir

Entry-Tier, Honest Foundation

The South Island's cooler climate and shorter Manuka season produce lower-MGO Manuka, typically UMF 5–10 and 83–263 mg/kg. This is not lower-quality honey — it is lower-activity honey, which is a measurement, not a judgment. It is still genuine, leptosperin-verified Manuka, still backed by government certification. It is simply the entry threshold.

What you get: real Manuka at the price point where daily use becomes defensible. Single-origin, certified, verifiable. A jar you would buy for regular table use without guilt.

AvailabilityWidely available

UMF5+ to 10+

The evidence

The research landscape — what's been characterized, and what stays in its lane.

Manuka has the deepest compositional research base of any honey, plus a parallel medical-device track that is genuinely separate from the food product. The page reads them as separate lanes: composition science on the honey itself; regulated-device research on the sterilized wound dressing (Medihoney). Both are real; neither carries over into a consumer health claim for jarred honey.

Composition chemistry (well-characterized): The DHA-to-MGO maturation pathway in Manuka nectar and honey is well-documented (Adams et al., 2008/2009). MGO concentration ranges, leptosperin authenticity markers, the four UMF factors (MGO + DHA + leptosperin + HMF), and the NZ MPI five-marker authenticity definition are all published, reproducible, and graded against. This is the foundation under the UMF and MGO certification systems — chemistry, not health claims.

Medical-device track (separate product, separate register): Medihoney is a sterilized, FDA 510(k)-cleared Class II wound dressing — a regulated medical device tested in RCTs for diabetic foot ulcers, surgical wounds, and burn dressings, and used under clinician supervision in hospital wound-care protocols. The mechanism is understood: MGO penetrates biofilm and maintains a moist wound environment. This is clinical-device research on a sterilized product, not a consumer-honey health claim. The March 2026 Integra/Medihoney recall after serious-injury reports is a useful reminder that even regulated devices are recalled and monitored like any other device — see the dedicated FAQ for the food/device firewall.

Moderate: Antimicrobial activity in vitro. Test-tube studies show Manuka's MGO active against a broad range of bacteria, including antibiotic-resistant strains. But in vitro activity is not the same as in vivo efficacy. What works in a petri dish may not work at the same scale in living tissue, and concentration matters enormously. These studies are important context, but they are not evidence of clinical use.

Emerging: Oral antimicrobial use. Small pilot studies and cell-culture work suggest Manuka honey may support oral health (throat lozenges, gum disease) and digestive health (gut microbiome). The mechanisms are plausible; the evidence is preliminary. Any claim that Manuka "heals the gut" or "kills H. pylori" is not yet supported by the literature.

Overclaimed: Systemic health benefits. You will find claims that Manuka boosts immunity, cures cancer, reverses diabetes, or provides systemic antibacterial benefits when consumed orally. None of these are supported by the clinical literature. Honey is a nutritious, low-osmotic-stress food. It is not medicine in the systemic sense. Do not buy Manuka expecting it to treat a chronic disease.

The honest summary: the clinical wound-care evidence sits with the sterilized medical-grade product (Medihoney), used under clinician supervision — not the jarred food honey. As a wellness practice, oral antimicrobial use is plausible but not proven superior to other options. Manuka is not a substitute for medical care for any condition.

When Manuka fits

When Manuka fits.

Manuka is the most-researched honey in the world. That's a fact, not a sales pitch — and it tells you exactly when to buy it and when not to. The peer-reviewed evidence concentrates on composition chemistry and on the sterilized medical-grade dressing used under clinician supervision. Daily wellness, immune support, and systemic health benefits are not supported. Spend on Manuka for verified chemistry and authentication, not as a treatment.

Buy Manuka when…

You want the honey with the highest verified MGO concentration and the deepest documented composition chemistry.
You want a distinctive, intensely herbaceous and earthy honey unlike anything in the floral or orchard families.
You want single-origin traceability — every certified jar tracks to a producer, region, harvest year, and batch number.
You value the strictest authentication infrastructure (UMF certification, leptosperin marker, batch traceability).

Pass on Manuka when…

Your goal is general daily honey — table use, sweetening, baking. The certification premium isn't earning its place here.
You're looking for systemic immune or digestive benefits from oral consumption. The clinical literature does not support these claims (see Clinical Research section above).
You want bold, distinctively flavored varieties for cooking — buckwheat, chestnut, or dark wildflower deliver more flavor per dollar.
You're allergy-sourcing — Manuka's exceptional pricing and limited production don't add anything for local-pollen wellness narratives.

If Manuka isn't fitting…

For darker, more assertively flavored honeys: buckwheat, dark wildflower, chestnut.
For similar Leptospermum chemistry: Jellybush (Australian, comparable MGO pathway) or Marri (Western Australia, peroxide-driven activity).
For everyday value: a UMF entry tier is genuine, certified Manuka — there's no chemistry reason to chase a higher number for table use.
For comparable cultural depth: Sidr (Yemen, Saudi Arabia) — different chemistry, a thousand-year reputation.

Under the microscope

What peer-reviewed research actually measures.

Manuka's clinical evidence is genuine. Below is a snapshot of what the research shows, in six dimensions, plus three landmark studies.

Where Manuka has been tested.

Each row anchors to a peer-reviewed study rendered in full in the Sources section below.

In vitro

Streptococcus pyogenes M28 (biofilm)
Bactericidal in vitro; permeated 24h established biofilms
Maddocks 2012, Microbiology
MRSA (planktonic)
EC 0.08–0.3 mg/mL MGO
Kilty 2011, Int Forum Allergy Rhinol
MRSA (biofilm)
EC 0.5–3.6 mg/mL MGO
Kilty 2011, Int Forum Allergy Rhinol
Clostridium difficile (4 ribotypes)
MIC / MBC 6.25% v/v
Piotrowski 2017, Eur J Clin Microbiol
Helicobacter pylori (5 isolates)
MIC 5% v/v in vitro — but McGovern 1999 in vivo follow-up showed no eradication
al Somal 1994, J R Soc Med

Clinical

Dental plaque + gingivitis
Plaque score 0.99 → 0.65 (p=0.001), N=30 pilot, 21 days
English 2004, J Int Acad Periodontol
Post-surgical eyelid wounds
RCT N=46; faster epithelialization, reduced infection — underpowered
Malhotra 2017, Ophthalmic Plast Reconstr Surg

Meta-analysis

Honey wound dressings (systematic review)
Honey may shorten healing time vs alternative dressings; evidence quality varied
Jull 2015, Cochrane Database Syst Rev
Chronic wound dressings (8 RCTs, 906 patients)
Healing time reduced by 17 days (95% CI −26 to −8, p=0.0003); 18% higher healing rate. Evidence quality rated very low — larger trials needed.
Tang 2024, Nutrients

Honest framing: Manuka has the deepest in vitro evidence base of any honey (Mavric 2008, Kato 2014, Kilty 2011, Maddocks 2012, Piotrowski 2017, Onyango & Liang 2024). Clinical RCTs remain limited and underpowered (Malhotra 2017, English 2004). The Cochrane (Jull 2015) and updated Tang 2024 meta-analyses find positive direction-of-effect for topical honey wound care but flag low overall evidence quality. Systemic-consumption claims lack supporting RCTs.

2008Mavric et al.

MGO identified as dominant antibacterial compound in Manuka

Analyzed the chemical composition of Manuka honey and identified methylglyoxal (38–761 mg/kg) as the primary non-peroxide antimicrobial agent. Demonstrated that MGO concentration directly correlated with in vitro bactericidal activity against clinical wound isolates. Established the scientific basis for MGO certification.

Mavric E et al. Mol Nutr Food Res 52(4):483–9. PMID 18210383. DOI 10.1002/mnfr.200700282

2014Kato et al.

Leptosperin as definitive authentication marker for Manuka honey

Identified leptosperin (3–10 mg/kg) as a Leptospermum scoparium-specific compound absent in all other honey tested. Established leptosperin presence as a molecular fingerprint for authentic Manuka. The discovery underpinned New Zealand's regulatory requirement for leptosperin in all exported Manuka.

Kato Y et al. J Agric Food Chem 62(27):6400–7. PMID 24941263. DOI 10.1021/jf501475h

2017Malhotra et al.

Effect of Manuka honey on eyelid wound healing: a randomized controlled trial

RCT in patients undergoing upper blepharoplasty. Two-arm design: Manuka honey applied with Vaseline vs Vaseline alone (no antibiotic-ointment comparator). Primary endpoint was wound healing — the paper also reported a lower secondary-outcome infection rate in the Manuka arm, with statistical power acknowledged as limited. Authors called for larger trials.

Malhotra R et al. Ophthalmic Plast Reconstr Surg 33(4):268–272. PMID 27429228. DOI 10.1097/IOP.0000000000000743

Honest framing. Manuka honey has robust in vitro evidence, and a separate sterilized medical-grade product (Medihoney) is FDA-cleared for topical wound care under clinician supervision. That device evidence is not the same as systemic efficacy from eating honey. Do not buy jarred Manuka expecting it to cure gut disease, boost immunity, or treat infections. For any wound that concerns you, see a clinician — jarred food honey is not a wound-care product.

Flavor profile

What a spoonful actually tastes like.

Manuka tastes like the bush it comes from — herbaceous, earthy, with a slow medicinal pull on the finish. Lower-tier Manuka skews lighter; high-UMF Manuka deepens into something approaching herbal liqueur, with a darker, more amber-toned caramel base. The “medicinal” quality isn't poetic license — at UMF 15+ and above, the chemistry that drives its antibacterial activity also drives its bitter finish.

Palate signature.

The nine-family flavor map for Manuka honey.

Herbaceous · 8

8 / 10

manuka-bush register, slow medicinal pull

Earthy · 8

8 / 10

mineral, warm, slightly bitter

Caramel · 5

5 / 10

darker amber tones at higher UMF

Woody · 4

4 / 10

soft tannin, structural

Floral, Fruity, Spicy, Nutty, and Bakery stay below the display threshold — Manuka's character is the bush itself, not the bouquet of orchard or meadow varieties. The medicinal-bitter finish is the variety's signature, not a defect.

The tier ladder

What you get at each tier.

Manuka's range is the widest of any honey on Melvea — spanning entry-tier certified jars to allocation-only premium. Each step represents a real difference in MGO content, certification rigor, and region.

The tiers below reflect the certified Manuka landscape as of spring 2026. Certified Manuka with a government-backed UMF or MGO rating is the baseline; anything without certification is not Manuka in the meaningful sense.

Entry Tier

Where most buyers should start

UMF: 5+ to 10
MGO: 80 to 250 mg/kg

The baseline of certified Manuka. Genuine, MGO-verified, traceable to a New Zealand producer. Mild, approachable character — pleasant table use, entry-level MGO. Where most regular buyers should start.

Mid Tier

The everyday sweet spot

UMF: 10 to 15
MGO: 250 to 514 mg/kg

The most common certified range. Most published research has used Manuka in this MGO band. Sturdier body, distinctive earthy-herbal flavor, deeper bitterness. Where most engaged buyers land.

Premium Tier

Where the chemistry intensifies

UMF: 15 to 20
MGO: 514 to 829 mg/kg

Where Manuka's chemistry intensifies. Higher MGO content correlates with stronger in vitro antibacterial activity (Mavric 2008). Bolder, more bitter presence on the palate. Buyers in this tier are usually after maximum verified MGO and the most intense flavor — not general consumption.

Allocation-Only

Limited-supply specialty

UMF: 20+ to 30+
MGO: 829+ to 1200+ mg/kg

Limited-supply Manuka from specific regions and producers. Sold in small batches, often pre-allocated to importers before reaching retail. Reserve for collectors and maximum-MGO seekers; most consumers do not need this tier.

Before you buy

Spot real Manuka — three checks.

Manuka fraud exists, but it is easier to catch than most premium honeys because of the certification infrastructure. Three things you can verify before you spend.

No. 01

UMF or MGO Registry Check

Visit umfha.org or mpi.govt.nz and verify the batch number and UMF/MGO rating. If the seller claims UMF 15+ but the registry shows UMF 5+, the jar is mislabeled. This is the fastest, most definitive test.

No. 02

Label Indicators

Look for "Product of New Zealand" (good), not "Packed in New Zealand" or "Sourced from New Zealand" (vague). Genuine Manuka labels carry UMF or MGO certifications, leptosperin mention, and batch numbers. Generic "Manuka" without any of these is a red flag.

No. 03

Price Floor Test

Certified UMF 10+ Manuka retails at a significant premium over commodity honey — a jar priced like grocery-store clover is suspect. If you find Manuka labeled UMF 15+ at bargain prices, the labeling is almost certainly wrong — either it is mislabeled, or it is a loss-leader with undisclosed sourcing.

The three things to know

What the numbers, the fraud, and the name actually tell you.

Three plain-language cards that replace the consumer-health register most manuka pages drift into. The chemistry behind the grading is real and explained here; the implication that the chemistry is a health prescription is not.

What the numbers actually mean

MGO 250, UMF 15 — the numbers on a manuka jar measure how much of the honey's signature natural compound (methylglyoxal) is in it. A higher number means more concentrated, and more thoroughly verified as the real thing. It's a grading and authenticity scale — not a health score. The chemistry behind it (MGO formed from DHA over the honey's first 1–2 years post-harvest, characterized in Mavric 2008 and Adams 2009) is composition science; the grading systems certify what is in the jar, not what it will do in a body.

Why manuka gets faked so often

New Zealand makes around 1,700 tonnes of manuka a year — but more than 10,000 tonnes are sold worldwide under the name. That gap is exactly why genuine manuka is tested against a strict marker standard before it's allowed to wear the label. The NZ MPI five-marker authenticity definition and the leptosperin marker characterized in Kato 2014 are the chemistry behind the certification machinery that exists because the fraud problem is real.

Who's even allowed to call it ‘manuka’?

Manuka is a M&amacr;ori word for a plant that grows on both sides of the Tasman Sea — so New Zealand and Australia have spent years fighting over the name. New Zealand tried to trademark it; courts in the UK (UK IPO, 2021), the EU (GI bid rejected), and New Zealand itself (IPONZ, May 2023) all ruled that “manuka” is a descriptive word anyone can use. The M&amacr;ori-taonga argument carries weight in the cultural debate; the legal conclusion is that the word belongs to no country. The product distinction (NZ L. scoparium under UMF; Australian Leptospermum under TA) is still real even where the naming distinction is not.

Wound-healing research on Medihoney (the sterilized, FDA-cleared Class II wound dressing) is reviewed separately above; it is a regulated medical device, not equivalent to jarred consumer manuka honey. See the dedicated FAQ for the device/food firewall. Never give any honey to infants under 12 months due to botulism risk.

Manuka is produced by commercial apiaries under government certification.

Unlike Sidr or Himalayan cliff honey, Manuka is not wild-harvested. It is produced by commercial beekeepers who manage Leptospermum scoparium apiaries in New Zealand and Tasmania, often placing hives on private land, in national reserves, or on leased pastoral ground. Production is seasonal (2–6 weeks), but it is commercial, audited, and government-regulated.

New Zealand beekeepers are organized into cooperative marketing groups, which together supply the global market. The supply chain is transparent — far more so than any other premium honey. Every certified jar can be traced to a producer, a region, a harvest year, and a batch number. If you are buying Manuka, you are buying from a known, named, regulated producer.

Common questions

Eleven honest answers about Manuka.

What is the difference between UMF and MGO ratings?

UMF (Unique Manuka Factor) measures three compounds: leptosperin, MGO, and non-peroxide antimicrobial activity. It is an aggregate rating backed by the New Zealand beekeeping association. MGO is a direct measurement of methylglyoxal content only, in mg/kg. Both correlate: UMF 15+ approximates MGO 514+. Choose whichever you find clearer; both are valid certifications. Budget Manuka with neither is not Manuka.

Why is Manuka relatively rare?

Leptospermum scoparium is endemic to New Zealand and parts of southeastern Australia -- it does not grow at commercial scale anywhere else. The tree flowers for only 2-6 weeks per season, and poor weather can shorten or eliminate a harvest entirely. Every jar of certified Manuka must pass third-party UMF or MGO lab testing, and every export shipment must meet MPI leptosperin requirements -- certification infrastructure that adds real cost at the producer level. The result is a narrow production window, a geographically locked supply, and a verification burden that most honeys never face.

How do I know my Manuka honey is real?

Three checks: (1) verify the UMF or MGO rating on the UMF HA website or MPI registry using the batch number; (2) check for 'Product of New Zealand' and certification badges on the label; (3) confirm the jar carries a verifiable batch number that traces to a licensed producer. A jar with a batch number that does not verify warrants skepticism.

What's the difference between New Zealand and Australian Manuka?

Both come from Leptospermum trees and carry comparable MGO content. New Zealand Manuka (Leptospermum scoparium) is regulated under UMF standards and leptosperin requirements. Australian Manuka (Leptospermum laevigatum and L. petersonii) is certified under the TA (Total Activity) system. Both are real, both are certified, both carry comparable chemistry. If you want New Zealand specifically, the label will say so.

What does the research on Manuka and wound care actually say?

The clinical wound-care evidence is for sterilized, medical-grade product (Medihoney) used under clinician supervision -- a regulated medical device, not the jar on your shelf. Jarred food-grade Manuka is not a wound-care product, and Melvea doesn't position it as one. For any wound that concerns you, see a clinician; never use honey as a substitute for professional wound care.

Is Manuka safe for children or infants?

Never give any honey -- including Manuka -- to infants under 12 months due to the risk of infant botulism. For children over one year, Manuka is safe as a food and sweetener, like any honey. All honey carries the same botulism risk under age one; Manuka is not special in this regard.

Does Manuka honey help with gut health?

Honey is gentle on the digestive system and carries prebiotic properties documented in nutrition research. But claims that Manuka 'heals the gut' or 'treats SIBO' or 'reverses dysbiosis' are not supported by clinical trials. If you have a digestive condition, consult a gastroenterologist -- they may support honey as a gentle sweetener, but not as a treatment. Do not buy Manuka expecting it to cure a gut disease.

What do the UMF and MGO numbers actually tell you?

They measure how concentrated the honey's signature compound (methylglyoxal) is, and they certify it's genuine manuka. Higher numbers mean more concentrated and more rigorously tested — not 'more medicine.' A UMF 5+ jar is just as authentic and leptosperin-verified as a UMF 20+ jar; it simply has less MGO. Pick the tier that fits your budget and taste — there's no health reason to chase a higher number.

Is Medihoney the same as the Manuka honey in a jar?

No. Medihoney is a sterilized, FDA-cleared Class II wound dressing used under medical supervision — a regulated medical device, not a food product. Jarred consumer manuka carries none of those clearances and is not equivalent to a wound-care product. Medical-grade isn't risk-free either: a March 2026 Integra/Medihoney recall after serious-injury reports is a useful reminder that regulated devices are recalled and monitored like any other device. The firewall is straightforward — Medihoney is a medical product for clinicians; manuka honey is food.

Does Manuka honey expire?

Honey does not truly expire when stored properly in a sealed container at room temperature. MGO levels peak around 1-2 years after production (as DHA finishes converting) and then very slowly decline over many years. For maximum MGO content, use within 2-3 years of the harvest date on the label. Crystallization is normal and does not indicate spoilage -- warm gently to re-liquefy.

What does Manuka honey taste like?

Rich, earthy, and distinctly different from most honeys. You will notice herbal or medicinal undertones -- slightly bitter, with a warming quality. Higher UMF grades tend to be more intensely flavored and less sweet. Most people either love it or find it an acquired taste. It is less sweet and more complex than clover honey and far more intense than acacia.

Explore more

Four varieties with a similar bold, bitter register.

References

Sources & further reading.

Grabek-Lejko, G.D. et al. (2024). “The comparison of the antioxidant, antibacterial and antiviral potential of Polish coniferous honeydew honey and Manuka honey.”
Comparative physicochemical + bioactivity study of honeydew vs Manuka honey.
Scientific Reports, 14(1) · DOI 10.1038/s41598-024-82429-0
Onyango, L.A. & Liang, J. (2024). “Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes.”
Comprehensive 2024 review focusing specifically on Manuka honey as a non-antibiotic alternative against Staphylococcus species, with extended attention to small colony variant (SCV) phenotypes — clinically important antibiotic-resistant subpopulations associated with chronic and recurrent infections. Synthesizes mechanism (MGO + phenolics + cell-division disruption + gene expression effects), in vitro and in vivo efficacy, and antibiotic-synergy literature.
Frontiers in Cellular and Infection Microbiology, 14:1380289 · PMID 38868298 · PMC PMC11168119 · DOI 10.3389/fcimb.2024.1380289
Tang, Y. et al. (2024). “Efficacy and Safety of Honey Dressings in the Management of Chronic Wounds: An Updated Systematic Review and Meta-Analysis.”
Updated systematic review and meta-analysis (PRISMA-compliant, PROSPERO-registered) of randomized controlled trials evaluating honey dressings in chronic wound management. Searched nine electronic databases through March 2024. Eight RCTs included, 906 patients total. Outcomes meta-analyzed: wound healing time, healing percentage, healing rate, bacterial clearance time, hospital stay duration, pain scores.
Nutrients, 16(15):2455 · PMID 39125335 · PMC PMC11314015 · DOI 10.3390/nu16152455
Malhotra, R. et al. (2017). “Effect of Manuka Honey on Eyelid Wound Healing: A Randomized Controlled Trial.”
Randomized controlled trial in 46 patients undergoing eyelid surgery. Two-arm design: topical 100% Manuka honey cream (UMF 16+) vs standard chloramphenicol antibiotic ointment for prevention of post-surgical wound infection. Primary outcome wound healing time; secondary outcomes infection rate and patient comfort. Manuka group showed faster epithelialization and reduced infection but trial was acknowledged as underpowered.
Ophthalmic Plastic & Reconstructive Surgery, 33(4):268-272 · PMID 27429228 · DOI 10.1097/IOP.0000000000000743
Piotrowski, M. et al. (2017). “Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile.”
In vitro broth dilution susceptibility testing of Manuka honey against four clinically significant Clostridium difficile ribotypes (RT017, RT023, RT027, RT046). Determined minimal inhibitory and bactericidal concentrations. Also measured biofilm formation in vitro under Manuka honey treatment.
European Journal of Clinical Microbiology & Infectious Diseases, 36(9):1661-1664 · PMID 28417271 · DOI 10.1007/s10096-017-2980-1
Carter, D.A. et al. (2016). “Therapeutic Manuka Honey: No Longer So Alternative.”
Comprehensive review article synthesizing two decades of Manuka honey research. Covers chemistry (MGO origin and concentration ranges), antibacterial activity across Gram-positive and Gram-negative organisms, biofilm activity, mechanism of action including cell-division disruption, gene-expression effects on MRSA, and clinical use as topical wound treatment including FDA-cleared formulations.
Frontiers in Microbiology, 7:569 · PMID 27148246 · PMC PMC4837971 · DOI 10.3389/fmicb.2016.00569
Jull, A.B. et al. (2015). “Honey as a topical treatment for wounds.”
Cochrane systematic review of randomized controlled trials evaluating topical honey dressings for wound treatment across acute (burns, lacerations) and chronic (venous ulcers, diabetic foot) wound types. Assessed effects on healing time, infection rate, adverse events vs alternative dressings and topical treatments. Honey faster than antiseptic + gauze for partial-thickness burns; comparable to other regimens for diabetic foot ulcers.
Cochrane Database of Systematic Reviews, 2015(3):CD005083 · PMID 25742878 · PMC PMC9719456 · DOI 10.1002/14651858.CD005083.pub4
Kato, Y. et al. (2014). “Plausible Authentication of Manuka Honey and Related Products by Measuring Leptosperin with Methyl Syringate.”
HPLC-based characterization of leptosperin (methyl syringate 4-O-beta-D-gentiobioside) as a unique chemical marker specific to Leptospermum scoparium honey. Tested across regional New Zealand Manuka samples, Australian Leptospermum nectars, and non-Manuka honey types. Validated leptosperin presence as authentication fingerprint stable under storage.
Journal of Agricultural and Food Chemistry, 62(27):6400-6407 · PMID 24941263 · DOI 10.1021/jf501475h
Maddocks, S.E. et al. (2012). “Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins.”
In vitro assay measuring MIC, MBC, microscopy, and aggregation efficiency of Manuka honey against Streptococcus pyogenes (group A Streptococcus) M28 strain. Tested both planktonic and biofilm cultures. Higher concentrations needed for biofilm inhibition than planktonic. Mechanism: abrogation of bacterial adherence to fibronectin via reduced expression of binding proteins.
Microbiology, 158(Pt 3):781-790 · PMID 22294681 · DOI 10.1099/mic.0.053959-0
Kilty, S.J. et al. (2011). “Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms.”
In vitro biofilm assay determining effective concentration (EC) of methylglyoxal — the major non-peroxide antibacterial agent in Manuka honey — against 10 clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates and 10 Pseudomonas aeruginosa isolates. Tested both planktonic (free-swimming) and biofilm-embedded forms. Established biofilm model used.
International Forum of Allergy & Rhinology, 1(5):348-350 · PMID 22287464 · DOI 10.1002/alr.20073
Adams, C.J. et al. (2009). “The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey.”
Tracked the chemical origin of methylglyoxal in Manuka honey. Sampled fresh Manuka honey (low MGO, high DHA), aged Manuka (high MGO, lower DHA), and Manuka flower nectar (high DHA, no detectable MGO). Confirmed via storage experiments at 37C and DHA-spiking of clover honey that MGO is produced by non-enzymatic conversion of nectar-derived DHA during honey maturation.
Carbohydrate Research, 344(8):1050-1053 · PMID 19368902 · DOI 10.1016/j.carres.2009.03.020
Adams, C.J. et al. (2008). “Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey.”
HPLC isolation and chemical characterization of the antibacterial bioactive fraction of New Zealand Manuka honey. Identified methylglyoxal as a major bactericidal compound. Demonstrated that after neutralization of MGO, Manuka honey retained some bactericidal activity — indicating other antimicrobial components beyond MGO contribute to total activity.
Carbohydrate Research, 343(4):651-659 · PMID 18194804 · DOI 10.1016/j.carres.2007.12.011
Mavric, E. et al. (2008). “Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand.”
Chemical analysis identifying methylglyoxal (MGO) as the principal non-peroxide antibacterial compound in New Zealand Manuka honey. Measured MGO concentration range across commercial samples (38-761 mg/kg). Demonstrated direct dose-response correlation between MGO concentration and in vitro bactericidal activity against clinical wound isolates including S. aureus.
Molecular Nutrition & Food Research, 52(4):483-489 · PMID 18210383 · DOI 10.1002/mnfr.200700282
English, H.K.P. et al. (2004). “The effects of manuka honey on plaque and gingivitis: a pilot study.”
Pilot study with 30 volunteers randomly allocated to chew either a UMF 15 Manuka honey "chewable leather" or sugarless chewing gum for 10 minutes, 3 times daily after meals over 21 days. Plaque and gingival bleeding scores recorded before and after the trial. Statistically significant reductions in plaque and bleeding observed in Manuka group.
Journal of the International Academy of Periodontology, 6(2):63-67 · PMID 15125017
McGovern, D.P.B. et al. (1999). “Manuka honey against Helicobacter pylori.”
Small open-label clinical study of 12 non-diabetic patients with confirmed active H. pylori infection. 6 patients received Manuka honey alone (one tablespoon 4x/day for 2 weeks); 6 received Manuka plus omeprazole 20 mg twice daily for the same period. Manuka batch tested at non-peroxide antibacterial activity equivalent to 11.7% phenol. Outcome measured by 14C urea breath test.
Journal of the Royal Society of Medicine, 92(8):439 · PMID 10656024 · PMC PMC1297341 · DOI 10.1177/014107689909200832
al Somal, N. et al. (1994). “Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey.”
In vitro testing of Helicobacter pylori clinical isolates against Manuka honey using agar well diffusion assay and broth dilution. Compared against a non-Manuka peroxide-honey solution at 40% (which showed no sensitivity in H. pylori) to confirm non-peroxide activity. Determined MIC by inclusion of Manuka honey in agar.
Journal of the Royal Society of Medicine, 87(1):9-12 · PMID 8308841 · PMC PMC1294271 · DOI 10.1177/014107689408700106

The world's mostresearchedhoney — and the world's most verified.

The honey with the most rigorously verified chemistry — and the strictest authenticity standards in honey.

Quick facts

Methylglyoxal — the compound that makes Manuka special.

UMF, MGO, and NPA — three ways to measure the same thing.

UMF (Unique Manuka Factor)

MGO (Methylglyoxal)

NPA (Non-Peroxide Activity)

Leptosperin — the fingerprint of real Manuka.

Australia has its own Leptospermum — and New Zealand lost the trademark fight in three jurisdictions.

Three New Zealand regions, three price points.

Highest MGO, Highest Price

Mid-Tier Workhorse

Entry-Tier, Honest Foundation

The research landscape — what's been characterized, and what stays in its lane.

When Manuka fits.

What peer-reviewed research actually measures.

Where Manuka has been tested.

MGO identified as dominant antibacterial compound in Manuka

Leptosperin as definitive authentication marker for Manuka honey

Effect of Manuka honey on eyelid wound healing: a randomized controlled trial

What a spoonful actually tastes like.

Palate signature.

What you get at each tier.

Where most buyers should start

The everyday sweet spot

Where the chemistry intensifies

Limited-supply specialty

Spot real Manuka — three checks.

UMF or MGO Registry Check

Label Indicators

Price Floor Test

What the numbers, the fraud, and the name actually tell you.

What the numbers actually mean

Why manuka gets faked so often

Who's even allowed to call it ‘manuka’?

Manuka is produced by commercial apiaries under government certification.

Melvea-verified jars, independently scored.

Eleven honest answers about Manuka.

Four varieties with a similar bold, bitter register.

Sidr

Heather

Jarrah

Buckwheat

Sources & further reading.

Meet the Beekeepers

Comvita

Primal by Nature

Manukora

Manuka Health

Egmont Honey

Manawa Honey

Meet the Beekeepers

Comvita

Primal by Nature

Manukora

Manuka Health

Egmont Honey

Manawa Honey

The world's most
researched
honey — and the world's most verified.